{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "CNY", "exchange": "SHZ", "shortName": "ANHUI ANKE BIOTECH", "longName": "Anhui Anke Biotechnology (Group) Co., Ltd.", "messageBoardId": "finmb_66323113", "exchangeTimezoneName": "Asia/Shanghai", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "market": "cn_market", "esgPopulated": false, "regularMarketChangePercent": -0.19569919, "regularMarketPrice": 10.2, "marketState": "POSTPOST", "fiftyTwoWeekHighChangePercent": -0.17005697, "fiftyTwoWeekLow": 8.34, "fiftyTwoWeekHigh": 12.29, "earningsTimestamp": 1619607540, "earningsTimestampStart": 1651229940, "earningsTimestampEnd": 1651492800, "trailingAnnualDividendRate": 0.0, "trailingPE": 23.72093, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 0.43, "epsForward": 0.65, "epsCurrentYear": 0.52, "priceEpsCurrentYear": 19.615385, "sharesOutstanding": 1673260032, "bookValue": 1.918, "fiftyDayAverage": 11.2164, "fiftyDayAverageChange": -1.0164003, "fiftyDayAverageChangePercent": -0.09061734, "twoHundredDayAverage": 10.31615, "twoHundredDayAverageChange": -0.1161499, "twoHundredDayAverageChangePercent": -0.011259036, "marketCap": 17067251712, "forwardPE": 15.692308, "priceToBook": 5.3180394, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.2 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": -0.020000458, "regularMarketTime": 1683875071, "regularMarketDayHigh": 10.39, "regularMarketDayRange": "10.2 - 10.39", "regularMarketDayLow": 10.2, "regularMarketVolume": 10455790, "regularMarketPreviousClose": 10.22, "bid": 10.21, "ask": 10.22, "bidSize": 0, "askSize": 0, "fullExchangeName": "Shenzhen", "financialCurrency": "CNY", "regularMarketOpen": 10.25, "averageDailyVolume3Month": 13742499, "averageDailyVolume10Day": 15224760, "fiftyTwoWeekLowChange": 1.8599997, "fiftyTwoWeekLowChangePercent": 0.22302154, "fiftyTwoWeekRange": "8.34 - 12.29", "fiftyTwoWeekHighChange": -2.0900002, "firstTradeDateMilliseconds": 1256866200000, "symbol": "300009.SZ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "AnkeBio Building", "address2": "669 Changjiang Road, West", "city": "Hefei", "zip": "230088", "country": "China", "phone": "86 551 6531 9890", "fax": "86 551 6531 9895", "website": "https://www.ankebio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name. It also provides anti-sperm antibody, semen leukocyte peroxidase staining, one-time semen processing, sperm hypo-osmotic staining, sperm life detection, sperm staining detection, sperm acrosin detection, sperm DNA fragmentation staining, and leptin and immunohistochemical diagnostic kits. In addition, the company offers adhesive plasters, oral solutions, topical preparations, and ointments; peptide APIs; beauty care and anti-aging products; and synthetic drugs in the form of oral powders, dripping pills, and tablets and capsules. Further, it provides autosomal, sex chromosome, autosomal and sex chromosome combination, and other kits, as well as paternity testing set packages; tumor biological immunotherapy products; and DNA testing professional services. The company was founded in 2000 and is based in Hefei, China.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Lihua  Song", "age": 47, "title": "Chairman of Board of Directors and Pres", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yong Bin Wang", "age": 54, "title": "Financial Director", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jian Ping Yao", "age": 50, "title": "Sr. VP", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hai  Sheng", "age": 47, "title": "Sr. VP", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Hui  Zhao", "age": 48, "title": "VP & Director", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kun  Li", "age": 39, "title": "Director of Capital Operations & Sec. of the Board of Directors", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Xian Yu Du", "age": 52, "title": "Supervisor", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}